10Aug
Tobacco giant Philip Morris raises bid for respiratory drugmaker
Tobacco giant Philip Morris has raised its bid to buy respiratory drugmaker Vectura to more than £1bn. Vectura makes inhaled medicines and devices to treat respiratory illnesses such as asthma, and counts Novartis and GSK among its customers. The Marlboro cigarette maker increased its offer to £1.65 ($2.29) per share after US private equity firm Carlyle...
